These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 13966570)
1. Maintenance therapy of chronic psychotics with perphenazine. BARBOUR JP Am J Psychiatry; 1963 Aug; 120():176-7. PubMed ID: 13966570 [No Abstract] [Full Text] [Related]
2. Evaluation of perphenazine in the treatment of Haitian psychotics. BORDELEAU JM; LAZURE D; DESROSIERS M; DOUYON L; MORIN L Can Psychiatr Assoc J; 1963 Apr; 8():111-5. PubMed ID: 14013872 [No Abstract] [Full Text] [Related]
3. Trilafon treatment in psychotics. WEISS II; RUBINGER JH; SORIN M; RYZEN N Am J Psychiatry; 1958 Jun; 114(12):1118-9. PubMed ID: 13533657 [No Abstract] [Full Text] [Related]
4. [Perphenazine treatment of psychoses]. SCHOPMANS A; TEMPEL H Med Klin; 1958 Apr; 53(17):757-9. PubMed ID: 13551820 [No Abstract] [Full Text] [Related]
5. THE COMPARATIVE EFFECTIVENESS OF AMITRIPTYLINE, PERPHENAZINE, AND THEIR COMBINATION IN THE TREATMENT OF CHRONIC PSYCHOTIC FEMALE PATIENTS. HANLON TE; NUSSBAUM K; WITTIG B; HANLON DD; KURLAND AA J New Drugs; 1964; 4(1):52-60. PubMed ID: 14157086 [No Abstract] [Full Text] [Related]
11. [The treatment of endogenous depression with perphenazine and trihexyphenidyl. Relation to extrapyramidal symptomatology]. NAHUNEK K Acta Psychiatr Scand; 1962; 38():108-16. PubMed ID: 13937256 [No Abstract] [Full Text] [Related]
12. Trilafon in the treatment of chronically psychotic hospitalized patients. COHEN H; FREIREICH AZ Am J Psychiatry; 1958 Nov; 115(5):452-4. PubMed ID: 13583248 [No Abstract] [Full Text] [Related]
13. DRUG MAINTENANCE PROBLEMS OF REHABILITATED MENTAL PATIENTS: THE CURRENT DRUG DOSAGE "MERRY-GO-ROUND". FORREST FM; GEITER CW; SNOW HL; STEINBACH M Am J Psychiatry; 1964 Jul; 121():33-40. PubMed ID: 14154775 [No Abstract] [Full Text] [Related]
14. Perphenazine treatment in psychotics. WEISS II; RUBINGER JH; SORIN M; RYZEN N J Clin Exp Psychopathol; 1959; 20(1):44-52. PubMed ID: 13641391 [No Abstract] [Full Text] [Related]
15. [DYNAMIC STUDIES ON DRAWING IN THE COURSE OF TREATMENT WITH PSYCHOTROPIC AGENTS]. HARDI I Arch Psychiatr Nervenkr; 1964 Jan; 205():49-62. PubMed ID: 14161973 [No Abstract] [Full Text] [Related]
16. [The use of neuroleptics in psychiatric and general practice]. HOFF H; HOFMANN G Wien Med Wochenschr; 1963 Mar; 113():269-75. PubMed ID: 13963890 [No Abstract] [Full Text] [Related]
17. PERPHENAZINE (TRILAFON) METABOLISM IN PSYCHOTIC PATIENTS. HUANG CL; KURLAND AA Arch Gen Psychiatry; 1964 Jun; 10():639-46. PubMed ID: 14159263 [No Abstract] [Full Text] [Related]
18. REHABILITATION OF CHRONIC PSYCHOTICS. WHITE ME J Ir Med Assoc; 1964 Jan; 54():24-6. PubMed ID: 14105270 [No Abstract] [Full Text] [Related]
19. AN EVALUATION-INCENTIVE SYSTEM FOR CHRONIC PSYCHOTICS. ISAAC DM; LAFAVE HG Psychiatr Q Suppl; 1964; 38():33-47. PubMed ID: 14297902 [No Abstract] [Full Text] [Related]
20. SYMPTOM SPECIFICITY OF ANTI-PSYCHOTIC DRUGS. JENKINS SB; SAMBORSKI AH J Mich State Med Soc; 1964 Mar; 63():187-93. PubMed ID: 14132475 [No Abstract] [Full Text] [Related] [Next] [New Search]